Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Participants With Renal Impairment and in Healthy Participants With Normal Renal Function

​ Conditions: Chronic Hepatitis B Infection

Interventions: Drug: Pevifoscorvir Sodium (ALG-000184)

Sponsors: Aligos Therapeutics

Not yet recruiting Conditions: Chronic Hepatitis B Infection
Interventions: Drug: Pevifoscorvir Sodium (ALG-000184)
Sponsors: Aligos Therapeutics
Not yet recruiting